Zentalis Pharmaceuticals
ZNTL
ZNTL
66 hedge funds and large institutions have $1.05B invested in Zentalis Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 36 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less capital invested
Capital invested by funds: $1.28B → $1.05B (-$235M)
Holders
66
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$25.5M | |
| 2 | +$25.2M | |
| 3 | +$23.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.9M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$13.5M |
Top Sellers
| 1 | -$2.67M | |
| 2 | -$2.64M | |
| 3 | -$624K | |
| 4 |
D.E. Shaw & Co
New York
|
-$553K |
| 5 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$166K |